Sample | Title | Value | Rank |
GSM967852 | U87-EV human glioblastoma xenograft - Control 1 | 2.79489 | 33 |
GSM967853 | U87-EV human glioblastoma xenograft - Control 2 | 2.76156 | 34 |
GSM967854 | U87-EV human glioblastoma xenograft - Control 3 | 2.79387 | 35 |
GSM967855 | U87-EV human glioblastoma xenograft - Control 4 | 2.91572 | 42 |
GSM967856 | U87-EV human glioblastoma xenograft - Control 5 | 2.68371 | 32 |
GSM967862 | U87-EV human glioblastoma xenograft - Bevacizumab treated 1 | 2.9662 | 38 |
GSM967863 | U87-EV human glioblastoma xenograft - Bevacizumab treated 2 | 2.79236 | 33 |
GSM967864 | U87-EV human glioblastoma xenograft - Bevacizumab treated 3 | 2.75011 | 34 |
GSM967865 | U87-EV human glioblastoma xenograft - Bevacizumab treated 4 | 2.70466 | 32 |
GSM967857 | U87-EV human glioblastoma xenograft - dibenzazepine treated 1 | 2.74127 | 33 |
GSM967858 | U87-EV human glioblastoma xenograft - dibenzazepine treated 2 | 2.75611 | 34 |
GSM967859 | U87-EV human glioblastoma xenograft - dibenzazepine treated 3 | 2.74357 | 34 |
GSM967860 | U87-EV human glioblastoma xenograft - dibenzazepine treated 4 | 2.76609 | 34 |
GSM967861 | U87-EV human glioblastoma xenograft - dibenzazepine treated 5 | 2.75836 | 34 |